Concurrently, our in vitro functional assays independently validated its role as a potent oncogenic factor, demonstrating that silencing TRIP6 significantly suppressed the proliferation, migration, and invasion of colon cancer cells. Here, TRIP6 is linked to colonic neoplasm.